中信保诚中证800医药指数(LOF)C(013080)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
18,583,378.63 |
-24,856,705.35 |
-49,403,442.39 |
-17,282,275.02 |
| 利息合计 |
24,815.23 |
93,872.48 |
70,102.44 |
389,235.34 |
| 其中：存款利息收入 |
24,815.23 |
47,076.85 |
23,306.81 |
67,829.29 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-1,954,079.72 |
-14,390,937.70 |
-5,672,322.86 |
-28,140,594.85 |
| 其中：股票投资收益 |
-4,167,994.10 |
-18,458,296.78 |
-8,107,194.10 |
-31,160,084.91 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
2,213,914.38 |
4,067,359.08 |
2,434,871.24 |
3,019,490.06 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
20,479,093.95 |
-10,641,238.32 |
-43,832,475.98 |
10,217,223.59 |
| 其他收入 |
33,549.17 |
81,598.19 |
31,254.01 |
251,860.90 |
| 费用 |
1,543,845.22 |
3,040,563.35 |
1,510,453.02 |
4,156,239.85 |
| 管理人报酬 |
1,177,145.37 |
2,161,573.90 |
1,071,841.83 |
3,051,137.06 |
| 基金托管费 |
235,429.11 |
432,314.86 |
214,368.39 |
653,409.42 |
| 销售服务费 |
29,572.18 |
60,973.49 |
32,095.65 |
63,143.77 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
101,698.56 |
385,532.60 |
191,978.65 |
387,392.55 |
| 利润总额 |
17,039,533.41 |
-27,897,268.70 |
-50,913,895.41 |
-21,438,514.87 |
微信公众号
证券之星APP
基本资料
